Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Am J Physiol ; 277(2 Pt 2): H617-25, 1999 08.
Artículo en Inglés | MEDLINE | ID: mdl-10444487

RESUMEN

In the hypertrophied heart, increased extravascular forces acting to compress the intramural coronary vessels might require augmentation of metabolic vasodilator mechanisms to maintain adequate coronary blood flow. Vascular smooth muscle ATP-sensitive potassium (K(+)(ATP)) channel activity is important in metabolic coronary vasodilation, and adenosine contributes to resistance vessel dilation in the hypoperfused heart. Consequently, this study was performed to determine whether K(+)(ATP) channels and adenosine have increased importance in exercise-induced coronary vasodilation in the hypertrophied left ventricle. Studies were performed in dogs in which banding of the ascending aorta had resulted in a 66% increase in left ventricular mass in comparison with historic normal animals. Treadmill exercise resulted in increases of coronary blood flow that were linearly related to the increase of heart rate or rate-pressure product. During resting conditions, K(+)(ATP) channel blockade with glibenclamide caused a 17 +/- 5% decrease in coronary blood flow, similar to that previously observed in normal hearts. Unlike normal hearts, however, glibenclamide blunted the increase in coronary flow that occurred during exercise, causing a significant decrease in the slope of the relationship between coronary flow and the rate-pressure product. Adenosine receptor blockade with 8-phenyltheophylline did not alter coronary blood flow at rest or during exercise. Furthermore, even after K(+)(ATP) channel blockade with glibenclamide, the addition of 8-phenyltheophylline had no effect on coronary blood flow. This finding was different from normal hearts, in which the addition of adenosine receptor blockade after glibenclamide impaired exercise-induced coronary vasodilation. The data suggest that, in comparison with normal hearts, hypertrophied hearts have increased reliance on opening of K(+)(ATP) channels to augment coronary flow during exercise. Contrary to the initial hypothesis, however, adenosine was not mandatory for exercise-induced coronary vasodilation in the hypertrophied hearts either during control conditions or when K(+)(ATP) channel activity was blocked with glibenclamide.


Asunto(s)
Adenosina Trifosfato/fisiología , Adenosina/fisiología , Hipertrofia Ventricular Izquierda/fisiopatología , Canales de Potasio/fisiología , Animales , Circulación Coronaria , Perros , Combinación de Medicamentos , Gliburida/farmacología , Bloqueadores de los Canales de Potasio , Antagonistas de Receptores Purinérgicos P1 , Teofilina/análogos & derivados , Teofilina/farmacología
2.
Circ Res ; 84(4): 401-8, 1999 Mar 05.
Artículo en Inglés | MEDLINE | ID: mdl-10066674

RESUMEN

The hemodynamic abnormalities and neurohumoral activation that accompany congestive heart failure (CHF) might be expected to impair the increase in coronary blood flow that occurs during exercise. This study was performed to determine the effects of CHF on myocardial oxygen consumption and coronary blood flow during exercise. Coronary blood flow was measured in chronically instrumented dogs at rest, during 2 stages of graded treadmill exercise under control conditions (n=10), and after the development of CHF produced by 3 weeks of rapid ventricular pacing (n=9). In the normal dogs, coronary blood flow increased during exercise in proportion to the increase in the heart rate x the left ventricular systolic blood pressure product (RPP). After the development of CHF, resting myocardial blood flow was 25% lower than normal (P<0.05). Myocardial blood flow increased during the first stage of exercise, but then failed to increase further during the second stage of exercise despite an additional increase in the RPP. Myocardial oxygen consumption during exercise was significantly lower in animals with CHF and paralleled coronary flow. Despite the lower values for coronary blood flow in animals with CHF, there was no evidence for myocardial ischemia. Thus, even during the second level of exercise when coronary flow failed to increase, myocardial lactate consumption continued and coronary venous pH did not fall. In addition, the failure of coronary flow to increase as the exercise level was increased from stage 1 to stage 2 was not associated with a further increase in myocardial oxygen extraction. Thus, cardiac failure was associated with decreased myocardial oxygen consumption and failure of oxygen consumption to increase with an increase in the level of exercise. This abnormality did not appear to result from inadequate oxygen availability, but more likely represented a reduction of myocardial oxygen usage with a secondary decrease in metabolic coronary vasodilation.


Asunto(s)
Circulación Coronaria/fisiología , Insuficiencia Cardíaca/fisiopatología , Corazón/fisiopatología , Actividad Motora/fisiología , Consumo de Oxígeno/fisiología , Animales , Vasos Coronarios/metabolismo , Perros , Ecocardiografía , Insuficiencia Cardíaca/diagnóstico por imagen , Insuficiencia Cardíaca/patología , Ventrículos Cardíacos , Hemodinámica/fisiología , Concentración de Iones de Hidrógeno , Ácido Láctico/metabolismo , Miocardio/metabolismo , Miocardio/patología , Tamaño de los Órganos , Resistencia Vascular/fisiología , Venas/metabolismo
3.
Cutis ; 63(1): 21-3, 1999 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-9951589

RESUMEN

Frostbite is the occurrence of localized tissue freezing and injury. It results following cold exposure of sufficient magnitude or duration to cause acute tissue damage. Although there are several conditions that predispose to frostbite, all are at risk if subject to sufficient cold exposure. We discuss a case of frostbite presenting with bullae localized to the neck resulting from extreme cold encountered while snowmobiling at night in Minnesota, an entity known by some local practitioners as "polaris vulgaris."


Asunto(s)
Vesícula/etiología , Congelación de Extremidades/etiología , Congelación de Extremidades/patología , Vehículos a Motor Todoterreno , Recreación , Antiinfecciosos Locales/uso terapéutico , Vesícula/tratamiento farmacológico , Vesícula/patología , Frío/efectos adversos , Congelación de Extremidades/tratamiento farmacológico , Humanos , Masculino , Persona de Mediana Edad , Cuello , Sulfadiazina de Plata/uso terapéutico , Enfermedades de la Piel/patología , Viento
4.
J Virol ; 72(12): 9818-26, 1998 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-9811717

RESUMEN

Gene transfer with recombinant murine leukemia viruses (MuLV) provides the potential to permanently correct inherited lung diseases, such as cystic fibrosis (CF). Several problems prevent the application of MuLV-based recombinant retroviruses to lung gene therapy: (i) the lack of cell proliferation in mature pulmonary epithelia, (ii) inefficient gene transfer with a vector applied to the apical surface, and (iii) low titers of many retroviral preparations. We found that keratinocyte growth factor (KGF) stimulated proliferation of differentiated human tracheal and bronchial epithelia. Approximately 50% of epithelia divided in response to KGF as assessed by bromodeoxyuridine histochemistry. In airway epithelia stimulated to divide with KGF, high-titer ampho- and xenotropic enveloped vectors preferentially infected cells from the basal side. However, treatment with hypotonic shock or EGTA transiently increased transepithelial permeability, enhancing gene transfer with the vector applied to the mucosal surfaces of KGF-stimulated epithelia. Up to 35% of cells expressed the transgene after gene transfer. By using this approach, cells throughout the epithelial sheet, including basal cells, were targeted. Moreover, the Cl- transport defect in differentiated CF airway epithelia was corrected. These findings suggest that barriers to apical infection with MuLV can be overcome.


Asunto(s)
Factores de Crecimiento de Fibroblastos , Técnicas de Transferencia de Gen , Virus de la Leucemia Murina/genética , Proteínas de Transporte de Fosfato , Simportadores , Bronquios/citología , Bronquios/efectos de los fármacos , Bronquios/virología , Diferenciación Celular , División Celular/efectos de los fármacos , Permeabilidad de la Membrana Celular , Polaridad Celular , Células Cultivadas , Fibrosis Quística/genética , Fibrosis Quística/metabolismo , Fibrosis Quística/terapia , Regulador de Conductancia de Transmembrana de Fibrosis Quística/genética , Regulador de Conductancia de Transmembrana de Fibrosis Quística/metabolismo , Células Epiteliales/citología , Células Epiteliales/efectos de los fármacos , Células Epiteliales/virología , Factor 10 de Crecimiento de Fibroblastos , Factor 7 de Crecimiento de Fibroblastos , Expresión Génica , Sustancias de Crecimiento/administración & dosificación , Humanos , Receptores Virales/genética , Receptores Virales/fisiología , Proteínas Cotransportadoras de Sodio-Fosfato , Tráquea/citología , Tráquea/efectos de los fármacos , Tráquea/virología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA